Clinical Trials Browser

OTHER × Losartan × 30 days × Clear all

NCT05077800 2026-04-13

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Phase 2 Active not recruiting

Gastrointestinal

Pancreatic Adenocarcinoma

NCT05607017 2026-04-06

Losartan in Prevention of Radiation-Induced Heart Failure

Phase EARLY_PHASE1 Completed

Radiation Fibrosis Syndrome, Breast Neoplasms